AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Ludwig, M Riethmuller-Winzen, H Felberbaum, RE Olivennes, F Albano, C Devroey, P Diedrich, K
Citation: M. Ludwig et al., Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix, FERT STERIL, 75(1), 2001, pp. 18-22

Authors: Ludwig, M Felberbaum, RE Devroey, P Albano, C Riethmuller-Winzen, H Schuler, A Engel, W Diedrich, K
Citation: M. Ludwig et al., Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide (R)) in controlled ovarian stimulation for assisted reproduction, ARCH GYN OB, 264(1), 2000, pp. 29-32

Authors: Nikolettos, N Al-Hasani, S Felberbaum, R Demirel, LC Riethmuller-Winzen, H Reissmann, T Schopper, B Sturm, R Diedrich, K
Citation: N. Nikolettos et al., Comparison of cryopreservation outcome with human pronuclear stage oocytesobtained by the GnRH antagonist, Cetrorelix, and GnRH agonists, EUR J OB GY, 93(1), 2000, pp. 91-95

Authors: Felberbaum, RE Albano, C Ludwig, M Riethmuller-Winzen, H Grigat, M Devroey, P Diedrich, K
Citation: Re. Felberbaum et al., Ovarian stimulation far assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study, HUM REPR, 15(5), 2000, pp. 1015-1020

Authors: Albano, C Felberbaum, RE Smitz, J Riethmuller-Winzen, H Engel, J Diedrich, K Devroey, P
Citation: C. Albano et al., Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin, HUM REPR, 15(3), 2000, pp. 526-531

Authors: Albano, C Smitz, J Tournaye, H Riethmuller-Winzen, H Van Steirteghem, A Devroey, P
Citation: C. Albano et al., Luteal phase and clinical outcome after human menopausal gonadotrophin gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization intracytoplasmic sperm injection cycles, HUM REPR, 14(6), 1999, pp. 1426-1430
Risultati: 1-6 |